|
1
|
Refetoff S: Resistance to thyroid hormone:
One of several defects causing reduced sensitivity to thyroid
hormone. Nat Clin Pract Endocrinol Metab. 4:12008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Refetoff S, DeWind LT and DeGroot LJ:
Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter
and abnormally high PBI: Possible target organ refractoriness to
thyroid hormone. J Clin Endocrinol Metab. 27:279–294. 1967.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakurai A, Takeda K, Ain K, Ceccarelli P,
Nakai A, Seino S, Bell GI, Refetoff S and DeGroot LJ: Generalized
resistance to thyroid hormone associated with a mutation in the
ligand-binding domain of the human thyroid hormone receptor beta.
Proc Natl Acad Sci USA. 86:pp. 8977–8981. 1989; View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Onigata K and Szinnai G: Resistance to
thyroid hormone. Endocr Dev. 26:118–129. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lamberg BA, Rosengård S, Liewendahl K,
Saarinen P and Evered DC: Familial partial peripheral resistance to
thyroid hormones. Acta Endocrinol (Copenh). 87:303–312.
1978.PubMed/NCBI
|
|
6
|
Barkoff MS, Kocherginsky M, Anselmo J,
Weiss RE and Refetoff S: Autoimmunity in patients with resistance
to thyroid hormone. J Clin Endocrinol Metab. 95:3189–3193. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ahmed R, Al-Shaikh S and Akhtar M:
Hashimoto thyroiditis: A century later. Adv Anat Pathol.
19:181–186. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Corrias A, Cassio A, Weber G, Mussa A,
Wasniewska M, Rapa A, Gastaldi R, Einaudi S, Baronio F, Vigone MC,
et al: Thyroid nodules and cancer in children and adolescents
affected by autoimmune thyroiditis. Arch Pediatr Adolesc Med.
162:526–531. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Skarpa V, Kousta E, Tertipi A, Anyfandakis
K, Vakaki M, Dolianiti M, Fotinou A and Papathanasiou A:
Epidemiological characteristics of children with autoimmune thyroid
disease. Hormones (Athens). 10:207–214. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Taniyama M, Ishikawa N, Momotani N, Ito K
and Ban Y: Toxic multinodular goitre in a patient with generalized
resistance to thyroid hormone who harbours the R429Q mutation in
the thyroid hormone receptor beta gene. Clin Endocrinol (Oxf).
54:121–124. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Siristatidis C, Mastorakos G, Vitoratos N,
Gregoriou O, Iakovidou H, Salamalekis E and Creatsas G: Thyroid
hormone resistance and enlargement of the sella turcica during
pregnancy. Arch Gynecol Obstet. 269:152–155. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim HK, Kim D, Yoo EH, Lee JI, Jang HW,
Tan AH, Hur KY, Kim JH, Kim KW, Chung JH and Kim SW: A case of
resistance to thyroid hormone with thyroid cancer. J Korean Med
Sci. 25:1368–1371. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Paragliola RM, Lovicu RM, Locantore P,
Senes P, Concolino P, Capoluongo E, Pontecorvi A and Corsello SM:
Differentiated thyroid cancer in two patients with resistance to
thyroid hormone. Thyroid. 21:793–797. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sugita M, Harada H and Yamamoto T:
Perioperative management of a patient with thyroid hormone
resistance who underwent total thyroidectomy for thyroid cancer. J
Anesth. 26:595–597. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ramos-Prol A, Pérez-Lázaro M Antonia, del
Olmo-García M Isabel, León-de Zayas B, Moreno-Macián F, Navas-de
Solis S and Merino-Torres JF: Differentiated thyroid carcinoma in a
girl with resistance to thyroid hormone management with
triiodothyroacetic acid. J Pediatr Endocrinol Metab. 26:133–136.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Unluturk U, Sriphrapradang C, Erdoğan MF,
Emral R, Güldiken S, Refetoff S and Güllü S: Management of
differentiated thyroid cancer in the presence of resistance to
thyroid hormone and TSH-secreting adenomas: A report of four cases
and review of the literature. J Clin Endocrinol Metab.
98:2210–2217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vinagre J, Borges F, Costa A, Alvelos MI,
Mazeto G, Sobrinho-Simões M and Soares P: Differentiated thyroid
cancer in patients with resistance to thyroid hormone syndrome. A
novel case and a review of the literature. Front Mol Biosci.
1:102014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aoyama M, Yamasaki S and Tsuyuguchi M: A
case of resistance to thyroid hormone diagnosed after total
thyroidectomy for thyroid cancer. J Med Invest. 62:268–271. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Karakose M, Caliskan M, Arslan MS, Cakal
E, Yesilyurt A and Delibasi T: Thyroid hormone resistance in two
patients with papillary thyroid microcarcinoma and their BRAFV600E
mutation status. Arch Endocrinol Metab. 59:364–366. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cardoso LF, de Paula FJ and Maciel LM:
Resistance to thyroid hormone due to mutations in the THRB gene
impairs bone mass and affects calcium and phosphorus homeostasis.
Bone. 67:222–227. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lafranchi SH, Snyder DB, Sesser DE, Skeels
MR, Singh N, Brent GA and Nelson JC: Follow-up of newborns with
elevated screening T4 concentrations. J Pediatr. 143:296–301. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Refetoff S and Dumitrescu AM: Syndromes of
reduced sensitivity to thyroid hormone: Genetic defects in hormone
receptors, cell transporters and deiodination. Best Pract Res Clin
Endocrinol Metab. 21:277–305. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dumitrescu AM and Refetoff S: The
syndromes of reduced sensitivity to thyroid hormone. Biochim
Biophys Acta. 1830:3987–4003. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Weiss RE, Weinberg M and Refetoff S:
Identical mutations in unrelated families with generalized
resistance to thyroid hormone occur in cytosine-guanine-rich areas
of the thyroid hormone receptor beta gene. Analysis of 15 families.
J Clin Invest. 91:2408–2415. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Adams M, Matthews C, Collingwood TN, Tone
Y, Beck-Peccoz P and Chatterjee KK: Genetic analysis of 29 kindreds
with generalized and pituitary resistance to thyroid hormone.
Identification of thirteen novel mutations in the thyroid hormone
receptor beta gene. J Clin Invest. 94:506–515. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Collingwood TN, Wagner R, Matthews CH,
Clifton-Bligh RJ, Gurnell M, Rajanayagam O, Agostini M, Fletterick
RJ, Beck-Peccoz P, Reinhardt W, et al: A role for helix 3 of the
TRbeta ligand-binding domain in coactivator recruitment identified
by characterization of a third cluster of mutations in resistance
to thyroid hormone. EMBO J. 17:4760–4770. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Puzianowska-Kuznicka M, Krystyniak A,
Madej A, Cheng SY and Nauman J: Functionally impaired TR mutants
are present in thyroid papillary cancer. J Clin Endocrinol Metab.
87:1120–1128. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Suzuki H, Willingham MC and Cheng SY: Mice
with a mutation in the thyroid hormone receptor beta gene
spontaneously develop thyroid carcinoma: A mouse model of thyroid
carcinogenesis. Thyroid. 12:963–969. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ying H, Suzuki H, Furumoto H, Walker R,
Meltzer P, Willingham MC and Cheng SY: Alterations in genomic
profiles during tumor progression in a mouse model of follicular
thyroid carcinoma. Carcinogenesis. 24:1467–1479. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Agrawal NK, Goyal R, Rastogi A, Naik D and
Singh SK: Thyroid hormone resistance. Postgrad Med J. 84:473–477.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kammoun I, Bouzid C, Kandara H, Ben Salem
L, Turki Z and Ben Slama C: A Case of resistance to thyroid hormone
with Chronic thyroiditis: Discovery of a novel mutation (I54V).
Case Rep Endocrinol. 2011:5849302011.PubMed/NCBI
|
|
32
|
Sato H, Koike Y, Honma M, Yagame M and Ito
K: Evaluation of thyroid hormone action in a case of generalized
resistance to thyroid hormone with chronic thyroiditis: Discovery
of a novel heterozygous missense mutation (G347A). Endocr J.
54:727–732. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Aksoy DY, Gurlek A, Ringkananont U, Weiss
RE and Refetoff S: Resistance to thyroid hormone associated with
autoimmune thyroid disease in a Turkish family. J Endocrinol
Invest. 28:379–383. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sato H and Sakai H: A family showing
resistance to thyroid hormone associated with chronic thyroiditis
and its clinical features: A case report. Endocr J. 53:421–425.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gavin C, Meggison H and Ooi TC: Proposing
a causal link between thyroid hormone resistance and primary
autoimmune hypothyroidism. Med Hypotheses. 70:1024–1028. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dailey ME, Lindsay S and Skahen R:
Relation of thyroid neoplasms to Hashimoto disease of the thyroid
gland. AMA Arch Surg. 70:291–297. 1955. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim KW, Park YJ, Kim EH, Park SY, Park DJ,
Ahn SH, Park DJ, Jang HC and Cho BY: Elevated risk of papillary
thyroid cancer in Korean patients with Hashimoto's thyroiditis.
Head Neck. 33:691–695. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Repplinger D, Bargren A, Zhang YW, Adler
JT, Haymart M and Chen H: Is Hashimoto's thyroiditis a risk factor
for papillary thyroid cancer? J Surg Res. 150:49–52. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Matesa-Anic D, Matesa N, Dabelić N and
Kusić Z: Coexistence of papillary carcinoma and Hashimoto's
thyroiditis. Acta Clin Croat. 48:9–12. 2009.PubMed/NCBI
|
|
40
|
Koibuchi H, Omoto K, Fukushima N,
Toyotsuji T, Taniguchi N and Kawano M: Coexistence of papillary
thyroid cancer and Hashimoto thyroiditis in children: Report of 3
cases. J Ultrasound Med. 33:1299–1303. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yi JW, Park JY, Sung JY, Kwak SH, Yu J,
Chang JH, Kim JH, Ha SY, Paik EK, Lee WS, et al: Genomic evidence
of reactive oxygen species elevation in papillary thyroid carcinoma
with Hashimoto thyroiditis. Endocr J. 62:857–877. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Trovisco V, Soares P, Preto A, Castro P,
Máximo V and Sobrinho-Simões M: Molecular genetics of papillary
thyroid carcinoma: Great expectations. Arq Bras Endocrinol Metabol.
51:643–653. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sobrinho-Simões M, Máximo V, Rocha AS,
Trovisco V, Castro P, Preto A, Lima J and Soares P: Intragenic
mutations in thyroid cancer. Endocrinol Metab Clin North Am.
37333–362. (viii)2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cameselle-Teijeiro J, Abdulkader I,
Pérez-Becerra R, Vázquez-Boquete A, Alberte-Lista L, Ruiz-Ponte C,
Forteza J and Sobrinho-Simões M: BRAF mutation in solid cell nest
hyperplasia associated with papillary thyroid carcinoma. A
precursor lesion? Hum Pathol. 40:1029–1035. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fugazzola L, Puxeddu E, Avenia N, Romei C,
Cirello V, Cavaliere A, Faviana P, Mannavola D, Moretti S, Rossi S,
et al: Correlation between B-RAFV600E mutation and
clinico-pathologic parameters in papillary thyroid carcinoma: Data
from a multicentric Italian study and review of the literature.
Endocr Relat Cancer. 13:455–464. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Boelaert K: The association between serum
TSH concentration and thyroid cancer. Endocr Relat Cancer.
16:1065–1072. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Haymart MR, Repplinger DJ, Leverson GE,
Elson DF, Sippel RS, Jaume JC and Chen H: Higher serum thyroid
stimulating hormone level in thyroid nodule patients is associated
with greater risks of differentiated thyroid cancer and advanced
tumor stage. J Clin Endocrinol Metab. 93:809–814. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Medenica S, Radojevic N, Stojkovic M,
Nedeljkovic-Beleslin B, Savic S, Ciric J, Trbojevic B and Zarkovic
M: Autoimmunity and thyrotropin level in developing thyroid
malignancy. Eur Rev Med Pharmacol Sci. 19:2824–2829.
2015.PubMed/NCBI
|
|
49
|
Dulgeroff AJ, Geffner ME, Koyal SN, Wong M
and Hershman JM: Bromocriptine and Triac therapy for
hyperthyroidism due to pituitary resistance to thyroid hormone. J
Clin Endocrinol Metab. 75:1071–1075. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ohzeki T, Hanaki K, Motozumi H, Ohtahara
H, Ishitani N, Urashima H, Tsukuda T, Shiraki K, Sasaki S, Nakamura
H, et al: Efficacy of bromocriptine administration for selective
pituitary resistance to thyroid hormone. Horm Res. 39:229–234.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Pyo JS, Sohn JH and Kang G: BRAF
Immunohistochemistry using Clone VE1 is strongly concordant with
BRAF(V600E) mutation test in papillary thyroid carcinoma. Endocr
Pathol. 26:211–217. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Roth RM, Hampel H, Arnold CA, Yearsley MM,
Marsh WL and Frankel WL: A modified Lynch syndrome screening
algorithm in colon cancer: BRAF immunohistochemistry is efficacious
and cost beneficial. Am J Clin Pathol. 143:336–343. 2015.
View Article : Google Scholar : PubMed/NCBI
|
